NewAmsterdam Pharma Company (NAMS) has released an update to notify the public and investors about a regulation fd disclosure.
NewAmsterdam Pharma Company N.V. updated its investor presentation and made it available on its website on January 22, 2024. The presentation is provided for information purposes only and is not to be considered part of the official filings for the Securities Exchange Act of 1934 or the Securities Act of 1933, nor is it to be used for liability under those sections. It also won’t be included in any future filings unless explicitly stated.
For further insights into NAMS stock, check out TipRanks’ Stock Analysis page.